PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Safety, PK of AKT and MEK Combination

Safety, PK of AKT and MEK Combination


Basic Trial Information

Protocol Phase:Phase I
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorPharmaceutical/Industry
Primary ID113886
Other IDNCT01138085
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: